Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Apolipoprotein-B100 (apoB100) is the essential protein for the assembly and secretion of very low density lipoproteins (VLDL) from liver. The hepatoma HepG2 cell line has been the cell line of choice for the study of synthesis and secretion of human apoB-100. Despite the general use of HepG2 cells to study apoB100 metabolism, they secrete relatively dense, lipid-poor particles compared with VLDL secreted in vivo. Recently, Huh-7 cells were adopted as an alternative model to HepG2 cells, with the implicit assumption that Huh-7 cells were superior in some respects of lipoprotein metabolism, including VLDL secretion. In this study we addressed the hypothesis that the spectrum of apoB100 lipoprotein particles secreted by Huh-7 cells more closely resembles the native state in human liver. We find that Huh-7 cells resemble HepG2 cells in the effects of exogenous lipids, microsomal triglyceride transfer protein (MTP)-inhibition, and proteasome inhibitors of apoB100 secretion, recovery, and degradation. In contrast to HepG2 cells, however, MEK-ERK inhibition does not correct the defect in VLDL secretion. Huh-7 cells do not appear to offer any advantages over HepG2 cells as a general model of human apoB100-lipoprotein metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., Steyn, K., Sanderson, J. E., Hasani, M., Volkova, E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61076-4 · Cited by 864
Fisher, E. A., & Ginsberg, H. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100068200 · Cited by 460
Self-citationFisher, E. A., Zhou, M., Mitchell, D. M., Wu, X., Omura, S., Wang, H., Goldberg, A. L., & Ginsberg, H. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20427 · Cited by 286
Self-citationPan, M., Cederbaum, A. I., Zhang, Y.-L., Ginsberg, H. N., Williams, K. J., & Fisher, E. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19197 · Cited by 279
Self-citationAn MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits
Wetterau, J. R., Gregg, R. E., Harrity, T. W., Arbeeny, C., Cap, M., Connolly, F., Chu, C.-H., George, R. J., Gordon, D. A., Jamil, H., et al. (1998) · Science · doi:10.1126/science.282.5389.751 · Cited by 267
Cotranslocational Degradation Protects the Stressed Endoplasmic Reticulum from Protein Overload
Oyadomari, S., Yun, C., Fisher, E. A., Kreglinger, N., Kreibich, G., Oyadomari, M., Harding, H. P., Goodman, A. G., Harant, H., Garrison, J. L., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.051 · Cited by 252
Self-citationOhsaki, Y., Cheng, J., Fujita, A., Tokumoto, T., & Fujimoto, T. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0659 · Cited by 205
Ubiquitin-Proteasome Pathway Mediates Intracellular Degradation of Apolipoprotein B
Yeung, S. J., Chen, S. H., & Chan, L. (1996) · Biochemistry · doi:10.1021/bi9618777 · Cited by 187
The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism
Ginsberg, H. N., & Fisher, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800090-jlr200 · Cited by 172
Self-citationLipid droplets are arrested in the ER membrane by tight binding of lipidated apolipoprotein B-100
Ohsaki, Y., Cheng, J., Suzuki, M., Fujita, A., & Fujimoto, T. (2008) · Journal of Cell Science · doi:10.1242/jcs.025452 · Cited by 152
Cited by
Items 101–129 of 129
Härdfeldt, J., Hodson, L., Larsson, L., Pedrelli, M., & Pramfalk, C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.02.009 · Cited by 6
“5 cells) with 2% human serum, instead of 10% FBS, to improve the phenotype of the cells, making them better suited for studies of lipid metabolism [13, 17, 22].”
BackgroundInfluentialiPSCs for modeling hepatotropic pathogen infections
Bove, G., Mehnert, A.-K., & Thi, V. L. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00013-4 · Cited by 5
Shinozaki, K., Honda, T., Yamaji, K., Sakanashi, E. N., Ichi, I., & Yamane, D. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100795 · Cited by 5
“5 cells, due to the relatively low expression levels of APOB and poor lip-idation compared to ApoB in PHHs (55, 56).”
Wang, H., Nikain, C. A., Amengual, J., Forest, M. L., Yu, Y. H., Wang, M. C., Watts, R., Lehner, R. S., Qiu, Y., Cai, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.05.570183 · Cited by 4
“To stimulate LD formation and VLDL lipidation, lipid synthesis was enhanced with 0.6 mM oleic acid (OA) complexed to fatty acid-free BSA (0.12 mM) at a molar ratio of 5:1[33].”
MethodInfluentialSelf-citationThree-dimensional liver organoids as a novel platform for studying hepatitis B virus infection
Kim, G. (2024) · Organoid · doi:10.51335/organoid.2024.4.e11 · Cited by 2
“Another major issue with hepatoma cell lines is the absence of key liver-specific functions, such as metabolic activity and immune responses [66,67].”
Jimenez, R., & Privalsky, M. L. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.044 · Cited by 2
Perrin‐Cocon, L., Vidalain, P., Jacquemin, C., Aublin‐Gex, A., Olmstead, K., Panthu, B., Rautureau, G. J. P., André, P., Nyczka, P., Hütt, M. ‐., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.973321 · Cited by 2
Chavarría-Cubel, I., Molina, Y. L., Babiy, B., Lerma, M., Martínez-Botas, J., de la Peña, G., Vallejo, M. T., Villanueva-Blanco, T., Gómez‐Coronado, D., Alcázar, A., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2025.159611 · Cited by 3
Hirai, A., Yoneyama, Y., Assi, I., Osonoi, S., Sakai, S., Ohtsu, K., & Takebe, T. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100774 · Cited by 2
“18 This may be a drawback in studying lipid accumulation related to TM6SF2 variants.”
Lipoprotein(a) carries triglyceride species associated with incident cardiovascular disease
Takov, K., Penkov, S., Pechlaner, R., Elbahtety, E., Yap, L. E., Schmidt, L. E., Berry, S. E., Hall, W. L., Singh, B., Willeit, J., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.121866 · Cited by 2
Examining MicroRNAs as Regulators of Hepatic Lipid Homeostasis and Hepatitis C Virus Replication
Singaravelu, R. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5541 · Cited by 1
“The viral particles derived from cell culture are generally of higher density and lack association to ApoB; this is attributed to deficiencies in the very low-density lipoprotein assembly and lipidation pathways in the HCV permissive, Huh7-derived human hepatoma cell lines (Meex et al., 2011).”
BackgroundSun, X., Liu, Y., Zhou, S., Wang, L., Wei, J., Hua, R., Shen, Z., & Yoshida, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1481019/v1 · Cited by 1
Analysis of the role of p7 protein function in hepatitis C virus life cycle
Atoom, A. M. (2014) · Memorial University Research Repository (Memorial University)
Investigating Genetic Risk Factors of Coronary Artery Disease Using Genome Editing
McVey, D. G. (2016) · Figshare
Roberts, J. L. (2015) · Lincoln (University of Nebraska)
UNDERSTANDING APOLIPOPROTEIN B’S ABILITY TO AGGREGATE THROUGH LIPID DROPLETS AND CHAPERONE HOLDASE
Doonan, L. M. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
Identification of Novel Phospholipid Transfer Protein Inhibitors by High-Throughput Screening
Hantani, R., Takahashi, Y., Sotani, T., & Hantani, Y. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219842210
Modelos celulares hepáticos para el estudio del metabolismo de los lípidos. Revisión de literatura
Osma, J. A., Loango‐Chamorro, N., & Landázuri, P. (2019) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v67n1.64964 · Cited by 6
Kwon, J., & Budyak, E. I. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.20.539653
Soubeyrand, S., Lau, P., & McPherson, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.11.575239
“For instance, they display impaired lipoprotein secretion 24,25 .”
BackgroundSoubeyrand, S., Lau, P., & McPherson, R. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1548582
Sun, X., Liu, Y., Zhou, S., Wang, L., Wei, J., Hua, R., Shen, Z., & Yoshida, S. (2022) · Figshare · doi:10.6084/m9.figshare.20267715
Characterization of Hepatitis C Virus interaction with heparan sulfate proteoglycans
Xu, Y. (2014) · theses.fr (ABES) · doi:10.70675/b8c9dc27z15cfz4921zad5czee757d47d341
“This could be explained by the deficiency in lipoprotein assembly of Huh7 and Huh7-derived cell lines (Icard et al., 2009; Meex et al., 2011).”
Metadata
- Authors
- Meex, S. J. R., Andreo, U., Sparks, J. D., & Fisher, E. A.
- Affiliations
- NYU Langone Health (US)
- University of Rochester Medicine (US)
- New York University (US)
- Corresponding author
- Fisher, Edward A.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 52
- Issue
- 1
- Pages
- 152-158
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC2999930
- OpenAlex
- W1980467489
- Cited by
- 129
- References
- 21
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 12 · 2020: 11 · 2019: 8 · 2018: 8 · 2017: 4 · 2016: 9 · 2015: 12 · 2014: 14 · 2013: 8 · 2012: 11
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3577 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- National Heart, Lung, and Blood Institute (HL 58541, R01HL058541)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- apolipoprotein B-100, VLDL secretion, Huh7 cells, HepG2 cells, cell line comparison, microsomal triglyceride transfer protein, MEK/ERK signaling, proteasome inhibitors, hepatocyte models, lipoprotein assembly
- MeSH terms
- Cell Line, Humans, Lipoproteins, VLDL, Models, Biological, Extracellular Signal-Regulated MAP Kinases, Apolipoprotein B-100, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.